Isis spin-out Organox closes series D round

16th April 2014

OrganOx, a late-stage medical device company focused on increasing the quality and supply of organs for transplantation, has announced that it has closed a Series D Investment round.

The capital raising was oversubscribed and supported by both existing and new investors.

The company was spun-out by Oxford University Innovation in 2008 based on technology from Oxford’s Institute of Biomedical Engineering.

Dr Les Russell, CEO of OrganOx, said: “We are delighted at the level of support shown by our current investors and offer a very warm welcome to our newinvestors. Following the completion of the recruitment of all the patients in our first clinical study, we are now preparing for our major COPE (Consortium for Organ Preservation in Europe) clinical study starting shortly and funded with support from the European Union. The new funding will allow us to gear up in preparation for our commercial product launch later in the year once we have secured the CE Mark.”

 

Press release sign up